10x Genomics (TXG) Amortization of Deferred Charges (2025 - 2026)
10x Genomics (TXG) reported Amortization of Deferred Charges of $2.0 million for Q1 2026, up 8.98% on a YoY basis from $1.8 million in Q1 2025, and up 8.98% sequentially from $1.8 million in Q1 2025.
10x Genomics (TXG) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends
10x Genomics (TXG) has 2 years of Amortization of Deferred Charges data on file, last reported at $2.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 32.28 Bn | 24.97 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.62 Bn | 13.72 Bn | 482.22 Mn |
| 3 | Healthequity | 8.35 Bn | 8.08 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.98 Bn | 5.67 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn |
| 6 | MiniMed | 4.50 Bn | 4.20 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.47 Bn | 4.41 Bn | 216.84 Mn |
| 8 | Doximity | 3.96 Bn | 3.21 Bn | 125.97 Mn |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - |
| 10 | Omnicell | 1.89 Bn | 1.65 Bn | 140.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.95 Mn |
| Mar 31, 2026 | 1.95 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.79 Mn |